Are platelets cells? And if yes, are they immune cells?

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Garraud, Olivier ^a,b   Cognasse, Fabrice ^b,c  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Cell biology; Cell physiology; Cytokines; Hemostasis; Immunopathology; Immunophysiology; Platelets

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CD34 ANTIGEN; CYTOKINE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; CELLULAR IMMUNITY; EXTRACELLULAR TRAP; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MEGAKARYOCYTE; PLATELET MICROPARTICLE; REVIEW; THROMBOCYTE; TISSUE REPAIR;

EID: 84926681533     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00070     Document Type: Review

References (147)

1. Gazzaniga V, Ottini L. The discovery of platelets and their function. Vesalius (2011) 7:22-6. Available from: http://www.biusante.parisdescartes.fr/ishm/vesalius/VESx2001x07x01x022x026.pdf
2. Kuter DJ. Milestones in understanding platelet production: a historical overview. Br J Haematol (2014) 165:248-58. doi: 10.1111/bjh.12781
3. Panuganti S, Schlinker AC, Lindholm PF, Papoutsakis ET, Miller WM. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Eng Part A (2013) 19:998-1014. doi:10.1089/ten.TEA.2011.0111
4. Ye JY, Liang EY, Cheng YS, Chan GC, Ding Y, Meng F, et al. Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization. Stem Cells (2014) 32:2973-82. doi:10.1002/stem.1777
5. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 203:2433-40. doi:10.1084/jem.20061302
6. Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol (2008) 28:s17-24. doi:10.1161/ATVBAHA.107.160218
7. Rowley JW, Weyrich AS. Coordinate expression of transcripts and proteins in platelets. Blood (2013) 121:5255-6. doi:10.1182/blood-2013-03-487991
8. Shi DS, Smith MC, Campbell RA, Zimmerman PW, Franks ZB, Kraemer BF, et al. Proteasome function is required for platelet production. J Clin Invest (2014) 124:3757-66. doi:10.1172/JCI75247
9. Youssefian T, Masse JM, Rendu F, Guichard J, Cramer EM. Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa. Blood (1997) 89:4047-57.
10. Konstantinidis DG, Pushkaran S, Johnson JF, Cancelas JA, Manganaris S, Harris CE, et al. Signaling and cytoskeletal requirements in erythroblast enucleation. Blood (2012) 119:6118-27. doi:10.1182/blood-2011-09-379263
11. Palis J. Losing a "nucleus" to gain a cytoplasm. Blood (2012) 119:5948-9. doi:10.1182/blood-2012-04-422519
12. Hartwig J, Italiano J Jr. The birth of the platelet. J Thromb Haemost (2003) 1:1580-6. doi:10.1046/j.1538-7836.2003.00331.x
13. Italiano JE Jr, Shivdasani RA. Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost (2003) 1:1174-82. doi:10.1046/j.1538-7836.2003.00290.x
14. Deutsch VR, Tomer A. Megakaryocyte development and platelet production. Br J Haematol (2006) 134:453-66. doi:10.1111/j.1365-2141.2006.06215.x
15. Thon JN, Italiano JE. Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol (2012) 210:3-22. doi:10.1007/978-3-642-29423-5_1
16. Malara A, Balduini A. Blood platelet production and morphology. Thromb Res (2012) 129:241-4. doi:10.1016/j.thromres.2011.11.042
17. Machlus KR, Thon JN, Italiano JE Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol (2014) 165:227-36. doi:10.1111/bjh.12758
18. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 112:1506-19. doi:10.1161/CIRCRESAHA.113.300512
19. Weyrich AS, Zimmerman GA. Platelets in lung biology. Annu Rev Physiol (2013) 75:569-91. doi:10.1146/annurev-physiol-030212-183752
20. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 327:580-3. doi:10.1126/science.1181928
21. Flaumenhaft R, Mairuhu AT, Italiano JE. Platelet-and megakaryocyte-derived microparticles. Semin Thromb Hemost (2010) 36:881-7. doi:10.1055/s-0030-1267042
22. Italiano JE Jr, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 17:578-84. doi:10.1097/MOH.0b013e32833e77ee
23. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost (2011) 105(Suppl 1):S13-33. doi:10.1160/THS10-11-0720
24. Boilard E, Blanco P, Nigrovic PA. Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol (2012) 8:534-42. doi:10.1038/nrrheum.2012.118
25. Varki A. Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology (2011) 21:1121-4. doi:10.1093/glycob/cwr087
26. Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci (2012) 1253:16-36. doi:10.1111/j.1749-6632.2012.06517.x
27. Nguyen KA, Hamzeh-Cognasse H, Palle S, Anselme-Bertrand I, Arthaud CA, Chavarin P, et al. Role of siglec-7 in apoptosis in human platelets. PLoS One (2014) 9:e106239. doi:10.1371/journal.pone.0106239
28. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity (2003) 19:9-19. doi:10.1016/S1074-7613(03)00177-8
29. Garraud O, Cognasse F. Platelet toll-like receptor expression: the link between "danger" ligands and inflammation. Inflamm Allergy Drug Targets (2010) 9:322-33. doi:10.2174/187152810793937991
30. Garraud O, Berthet J, Hamzeh-Cognasse H, Cognasse F. Pathogen sensing, subsequent signalling, and signalosome in human platelets. Thromb Res (2011) 127:283-6. doi:10.1016/j.thromres.2010.10.015
31. Phipps RP. Platelets at the interface between thrombosis, inflammation and immunity. Thromb Res (2011) 127:179. doi:10.1016/j.thromres.2010.10.014
32. Refaai MA, Phipps RP, Spinelli SL, Blumberg N. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res (2011) 127:287-91. doi:10.1016/j.thromres.2010.10.012
33. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol (2011) 11:264-74. doi:10.1038/nri2956
34. Garraud O, Hamzeh-Cognasse H, Cognasse F. Platelets and cytokines: how and why? Transfus Clin Biol (2012) 19:104-8. doi:10.1016/j.tracli.2012.02.004
35. Garraud O, Hamzeh-Cognasse H, Pozzetto B, Cavaillon JM, Cognasse F. Bench-to-bedside review: platelets and active immune functions-new clues for immunopathology? Crit Care (2013) 17:236. doi:10.1186/cc12716
36. Zamora C, Canto E, Nieto JC, Ortiz MA, Diaz-Torne C, Diaz-Lopez C, et al. Functional consequences of platelet binding to T lymphocytes in inflammation. J Leukoc Biol (2013) 94(3):521-9. doi:10.1189/jlb.0213074
37. Liu F, Morris S, Epps J, Carroll R. Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Thromb Res (2002) 106:199-203. doi:10.1016/S0049-3848(02)00130-5
38. Malaver E, Romaniuk MA, D'Atri LP, Pozner RG, Negrotto S, Benzadon R, et al. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost (2009) 7:1333-43. doi:10.1111/j.1538-7836.2009.03492.x
39. Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, et al. Platelets and megakaryocytes contain functional nuclear factor-{kappa}B. Arterioscler Thromb Vasc Biol (2010) 30:591-8. doi:10.1161/ATVBAHA.109.197343
40. Spinelli SL, Maggirwar SB, Blumberg N, Phipps RP. Nuclear emancipation: a platelet tour de force. Sci Signal (2010) 3:e37. doi:10.1126/scisignal.3144pe37
41. Schattner M. Role of NF-kappaB pathway on platelet activation. Circ Res (2013) 113:e92. doi:10.1161/CIRCRESAHA.113.302333
42. Rivadeneyra L, Carestia A, Etulain J, Pozner RG, Fondevila C, Negrotto S, et al. Regulation of platelet responses triggered by toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factor-kappaB. Thromb Res (2014) 133:235-43. doi:10.1016/j.thromres.2013.11.028
43. Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, et al. Deciphering the human platelet sheddome. Blood (2011) 117:e15-26. doi:10.1182/blood-2010-05-283838
44. Adelson E, Rheingold JJ, Crosby WH. The platelet as a sponge: a review. Blood (1961) 17:767-74.
45. McRedmond JP, Park SD, Reilly DF, Coppinger JA, Maguire PB, Shields DC, et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics (2004) 3:133-44. doi:10.1074/mcp.M300063-MCP200
46. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 122:379-91. doi:10.1016/j.cell.2005.06.015
47. Gnatenko DV, Perrotta PL, Bahou WF. Proteomic approaches to dissect platelet function: half the story. Blood (2006) 108:3983-91. doi:10.1182/blood-2006-06-026518
48. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, et al. Platelet functions beyond haemostasis. J Thromb Haemost (2009) 7:1759-66. doi:10.1111/j.1538-7836.2009.03586.x
49. Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost (2009) 7:241-6. doi:10.1111/j.1538-7836.2008.03211.x
50. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood (2011) 118:e101-11. doi:10.1182/blood-2011-03-339705
51. Rowley JW, Schwertz H, Weyrich AS. Platelet mRNA: the meaning behind the message. Curr Opin Hematol (2012) 19:385-91. doi:10.1097/MOH.0b013e328357010e
52. Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci (2006) 34:125-30. doi:10.1016/j.transci.2005.09.002
53. Looney MR, Gilliss BM, Matthay MA. Pathophysiology of transfusion-related acute lung injury. Curr Opin Hematol (2010) 17:418-23. doi:10.1097/MOH.0b013e32833c07d3
54. Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Zeni F, et al. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol (2012) 145:189-200. doi:10.1016/j.clim.2012.09.004
55. Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmas P, Clemetson KJ, Nagy B Jr. Distinct effects of Re-and S-forms of LPS on modulating platelet activation. J Thromb Haemost (2013) 11(4):775-8. doi:10.1111/jth.12151
56. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, et al. Expression of toll-like receptors on human platelets. Thromb Res (2004) 113:379-85. doi:10.1016/j.thromres.2004.03.023
57. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional toll-like receptor-4. Blood (2005) 106:2417-23. doi:10.1182/blood-2005-03-0916
58. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of toll-like receptor molecules on human platelets. Immunol Cell Biol (2005) 83:196-8. doi:10.1111/j.1440-1711.2005.01314.x
59. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood (2006) 107:637-41. doi:10.1182/blood-2005-06-2202
60. Cognasse F, Semple JW, Garraud O. Platelets as potential immunomodulators: is there a role for platelet toll-like receptors? Curr Immunol Rev (2007) 3:109-15. doi:10.2174/157339507780655522
61. Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S, et al. Stimulation of toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res (2008) 104:346-54. doi:10.1161/CIRCRESAHA.108.185785
62. Panigrahi S, Ma Y, Hong L, Gao D, West XZ, Salomon RG, et al. Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyper-reactivity and thrombosis. Circ Res (2012) 112(1):103-12. doi:10.1161/CIRCRESAHA.112.274241
63. Thon JN, Peters CG, Machlus KR, Aslam R, Rowley J, Macleod H, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol (2012) 198:561-74. doi:10.1083/jcb.201111136
64. Anabel AS, Eduardo PC, Antonio HC, Carlos SM, Juana NM, Honorio TA, et al. Human platelets express toll-like receptor 3 and respond to poly I:C. Hum Immunol (2014) 75(12):1244-51. doi:10.1016/j.humimm.2014.09.013
65. Koupenova M, Vitseva O, Mackay CR, Beaulieu LM, Benjamin EJ, Mick E, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood (2014) 124:791-802. doi:10.1182/blood-2013-11-536003
66. Cloutier N, Pare A, Farndale RW, Schumacher HR, Nigrovic PA, Lacroix S, et al. Platelets can enhance vascular permeability. Blood (2012) 120:1334-43. doi:10.1182/blood-2012-02-413047
67. Herzog BH, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature (2013) 502:105-9. doi:10.1038/nature12501
68. Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A (2012) 109:13076-81. doi:10.1073/pnas.1200419109
69. Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost (2014) 40:277-83. doi:10.1055/s-0034-1370765
70. Tanaka K, Koike Y, Shimura T, Okigami M, Ide S, Toiyama Y, et al. In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model. PLoS One (2014) 9:e111888. doi:10.1371/journal.pone.0111888
71. Hattori R, Hamilton KK, McEver RP, Sims PJ. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem (1989) 264:9053-60.
72. Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Am J Physiol (1990) 258:C1100-7.
73. Wiedmer T, Sims PJ. Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood (1991) 78:2880-6.
74. Rinder CS, Smith MJ, Rinder HM, Cortright DN, Brodbeck RM, Krause JE, et al. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation. Ann Thorac Surg (2007) 83:146-52. doi:10.1016/j.athoracsur.2006.08.019
75. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res (2002) 22:913-22. doi:10.1089/10799900260286623
76. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol (2006) 4:445-57. doi:10.1038/nrmicro1425
77. Beaulieu LM, Freedman JE. The role of inflammation in regulating platelet production and function: toll-like receptors in platelets and megakaryocytes. Thromb Res (2010) 125:205-9. doi:10.1016/j.thromres.2009.11.004
78. Yeaman MR. Bacterial-platelet interactions: virulence meets host defense. Future Microbiol (2010) 5:471-506. doi:10.2217/fmb.09.112
79. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci (2010) 67:525-44. doi:10.1007/s00018-009-0210-4
80. Johansson D, Shannon O, Rasmussen M. Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One (2011) 6:e26928. doi:10.1371/journal.pone.0026928
81. Speth C, Rambach G, Lass-Florl C. Platelet immunology in fungal infections. Thromb Haemost (2014) 112:632-9. doi:10.1160/TH14-01-0074
82. Leytin V. Apoptosis in the anucleate platelet. Blood Rev (2012) 26:51-63. doi:10.1016/j.blre.2011.10.002
83. Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood (2010) 116:2011-8. doi:10.1182/blood-2010-01-261669
84. Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Selective triggering of platelet apoptosis, platelet activation or both. Br J Haematol (2013) 161(2):245-54. doi:10.1111/bjh.12237
85. Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost (2006) 4:2656-63. doi:10.1111/j.1538-7836.2006.02200.x
86. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med (2010) 10:369-73. doi:10.2174/156652410791316968
87. Hamzeh-Cognasse H, Cognasse F, Palle S, Chavarin P, Olivier T, Delezay O, et al. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol (2008) 9:54. doi:10.1186/1471-2172-9-54
88. Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, et al. Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol (2012) 2012:384685. doi:10.1155/2012/384685
89. Duerschmied D, Bode C, Ahrens I. Immune functions of platelets. Thromb Haemost (2014) 112:678-91. doi:10.1160/TH14-02-0146
90. Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. ScientificWorldJournal (2014) 2014:781857. doi:10.1155/2014/781857
91. Bik T, Sarov I, Livne A. Interaction between vaccinia virus and human blood platelets. Blood (1982) 59:482-7.
92. Polack B, Peyron F, Auriault C. Platelet cytotoxicity against parasites. Nouv Rev Fr Hematol (1991) 33:317-22.
93. Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol (2006) 80:8951-60. doi:10.1128/JVI.00136-06
94. White JG. Why human platelets fail to kill bacteria. Platelets (2006) 17:191-200. doi:10.1080/09537100500441234
95. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 13:463-9. doi:10.1038/nm1565
96. Cox D. Bacteria-platelet interactions. J Thromb Haemost (2009) 7:1865-6. doi:10.1111/j.1538-7836.2009.03611.x
97. Pleass RJ. Platelet power: sticky problems for sticky parasites? Trends Parasitol (2009) 25:296-9. doi:10.1016/j.pt.2009.04.002
98. Flaujac C, Boukour S, Cramer-Borde E. Platelets and viruses: an ambivalent relationship. Cell Mol Life Sci (2010) 67:545-56. doi:10.1007/s00018-009-0209-x
99. Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci (2010) 67:513-23. doi:10.1007/s00018-009-0207-z
100. McNicol A, Israels SJ. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol (2010) 88:510-24. doi:10.1139/y10-029
101. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost (2011) 9:1097-107. doi:10.1111/j.1538-7836.2011.04264.x
102. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, et al. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis (2012) 205:1321-9. doi:10.1093/infdis/jis180
103. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol (2013) 14:785-92. doi:10.1038/ni.2631
104. Brandt E, Ludwig A, Petersen F, Flad HD. Platelet-derived CXC chemokines: old players in new games. Immunol Rev (2000) 177:204-16. doi:10.1034/j.1600-065X.2000.17705.x
105. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 100:27-40. doi:10.1161/01.RES.0000252802.25497.b7
106. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol (2009) 40:123-34. doi:10.1165/rcmb.2008-0241TR
107. Schubert P, Devine DV. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang (2010) 99:112-22. doi:10.1111/j.1423-0410.2010.01333.x
108. Verschoor A, Langer HF. Crosstalk between platelets and the complement system in immune protection and disease. Thromb Haemost (2013) 110:910-9. doi:10.1160/TH13-02-0102
109. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation (2003) 10:335-50. doi:10.1038/sj.mn.7800198
110. Cognasse F, Garraud O. Human platelets exhibit infectious-pathogen binding ligands and participate to inflammation (and more?). Exp Hematol (2005) 33:1081-2. doi:10.1016/j.exphem.2005.06.033
111. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest (2005) 115:3378-84. doi:10.1172/JCI27196
112. Steinhubl SR. Platelets as mediators of inflammation. Hematol Oncol Clin North Am (2007) 21:115-21. doi:10.1016/j.hoc.2006.11.015
113. McNicol A, Israels SJ. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets (2008) 8:99-117. doi:10.2174/187152908784533739
114. Projahn D, Koenen RR. Platelets: key players in vascular inflammation. J Leukoc Biol (2012) 92:1167-75. doi:10.1189/jlb.0312151
115. Mantovani A, Garlanda C. Platelet-macrophage partnership in innate immunity and inflammation. Nat Immunol (2013) 14:768-70. doi:10.1038/ni.2666
116. Yan SL, Russell J, Harris NR, Senchenkova EY, Yildirim A, Granger DN. Platelet abnormalities during colonic inflammation. Inflamm Bowel Dis (2013) 19(6):1245-53. doi:10.1097/MIB.0b013e318281f3df
117. Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood (2014) 124:2173-83. doi:10.1182/blood-2014-05-573543
118. ANSM. Onzième rapport des données nationales d'hémovigilance. Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM). Saint-Denis: ANSM (2013). p. 1-91.
119. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev (2007) 21:99-111. doi:10.1016/j.blre.2006.06.001
120. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost (2008) 6:415-20. doi:10.1111/j.1538-7836.2007.02865.x
121. Kornerup KN, Salmon GP, Pitchford SC, Liu WL, Page CP. Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration. J Appl Physiol (2010) 109:758-67. doi:10.1152/japplphysiol.01086.2009
122. Manfredi AA, Rovere-Querini P, Maugeri N. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr Opin Hematol (2010) 17:3-8. doi:10.1097/MOH.0b013e3283324f97
123. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest (2012) 122:2661-71. doi:10.1172/JCI61303
124. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood (2000) 96:4046-54.
125. Menezes GB, McAvoy EF, Kubes P. Hyaluronan, platelets, and monocytes: a novel pro-inflammatory triad. Am J Pathol (2009) 174:1993-5. doi:10.2353/ajpath.2009.081138
126. Hottz ED, Medeiros-De-Moraes IM, Vieira-De-Abreu A, De Assis EF, Vals-De-Souza R, Castro-Faria-Neto HC, et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol (2014) 193:1864-72. doi:10.4049/jimmunol.1400091
127. Buchner K, Henn V, Grafe M, De Boer OJ, Becker AE, Kroczek RA. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis. J Pathol (2003) 201:288-95. doi:10.1002/path.1425
128. Danese S, De La Motte C, Reyes BM, Sans M, Levine AD, Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol (2004) 172:2011-5. doi:10.4049/jimmunol.172.4.2011
129. Elzey BD, Grant JF, Sinn HW, Nieswandt B, Waldschmidt TJ, Ratliff TL. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol (2005) 78:80-4. doi:10.1189/jlb.1104669
130. Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol (2005) 238:1-9. doi:10.1016/j.cellimm.2005.12.005
131. Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arterioscler Thromb Vasc Biol (2006) 26:1626-31. doi:10.1161/01.ATV.0000220374.00602.a2
132. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Chavarin P, Cogne M, Richard Y, et al. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol (2007) 35:1376-87. doi:10.1016/j.exphem.2007.05.021
133. Li N. Platelet-lymphocyte cross-talk. J Leukoc Biol (2008) 83:1069-78. doi:10.1189/jlb.0907615
134. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood (2008) 111:5028-36. doi:10.1182/blood-2007-06-097410
135. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Acquart S, Chavarin P, Courbil R, et al. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study. Transfusion (2009) 49:91-8. doi:10.1111/j.1537-2995.2008.01931.x
136. de Bruijne-Admiraal LG, Modderman PW, Von Dem Borne AE, Sonnenberg A. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood (1992) 80:134-42.
137. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood (2005) 105:178-85. doi:10.1182/blood-2004-06-2272
138. Li N, Ji Q, Hjemdahl P. Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J Thromb Haemost (2006) 4:874-81. doi:10.1111/j.1538-7836.2006.01817.x
139. Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, Schild H. Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood (2002) 99:3676-82. doi:10.1182/blood.V99.10.3676
140. Kaneider NC, Kaser A, Tilg H, Ricevuti G, Wiedermann CJ. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int J Immunopathol Pharmacol (2003) 16:225-31.
141. Hagihara M, Higuchi A, Tamura N, Ueda Y, Hirabayashi K, Ikeda Y, et al. Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro. J Immunol (2004) 172:5297-303. doi:10.4049/jimmunol.172.9.5297
142. Martinson J, Bae J, Klingemann HG, Tam Y. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. Cytotherapy (2004) 6:487-97. doi:10.1080/14653240410005249-1
143. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res (2009) 45(2-3):251-60. doi:10.1007/s12026-009-8106-9
144. Nomura S, Fujita S, Nakanishi T, Yokoi T, Shimamoto K, Miyamoto R, et al. Platelet-derived microparticles cause CD154-dependent activation of dendritic cells. Platelets (2012) 23:81-2. doi:10.3109/09537104.2011.595850
145. Sowa JM, Crist SA, Ratliff TL, Elzey BD. Platelet influence on T-and B-cell responses. Arch Immunol Ther Exp (2009) 57:235-41. doi:10.1007/s00005-009-0032-y
146. Chapman LM, Aggrey AA, Field DJ, Srivastava K, Ture S, Yui K, et al. Platelets present antigen in the context of MHC class I. J Immunol (2012) 189(2):916-23. doi:10.4049/jimmunol.1200580
147. Anani Sarab G, Moss M, Barker RN, Urbaniak SJ. Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells. Blood (2009) 114:1954-7. doi:10.1182/blood-2009-04-211839